Obagi Skintrinsiq Brightening Protocol
HOMOSALATE, OCTISALATE, AND ZINC OXIDE · KIT · Obagi Cosmeceuticals LLC
Obagi Skintrinsiq Brightening Protocol is a kit containing homosalate, octisalate, and zinc oxide. Manufactured by Obagi Cosmeceuticals LLC.
Key Facts
- Brand Name
- Obagi Skintrinsiq Brightening Protocol
- Generic Name
- HOMOSALATE, OCTISALATE, AND ZINC OXIDE
- NDC Code (Product)
62032-905- Manufacturer
- Obagi Cosmeceuticals LLC
- Dosage Form
- KIT
- Marketing Status
- Application #
- M020
- Marketing Start
- 08/01/2021
Recall History
No Recall HistoryFrequently Asked Questions
What is Obagi Skintrinsiq Brightening Protocol used for?
Obagi Skintrinsiq Brightening Protocol contains HOMOSALATE, OCTISALATE, AND ZINC OXIDE. It is a kit taken as directed. Consult your doctor for specific uses.
Is Obagi Skintrinsiq Brightening Protocol a controlled substance?
Obagi Skintrinsiq Brightening Protocol is not classified as a controlled substance by the DEA.
What is the generic name for Obagi Skintrinsiq Brightening Protocol?
The generic name for Obagi Skintrinsiq Brightening Protocol is HOMOSALATE, OCTISALATE, AND ZINC OXIDE. There are 7 other brand versions of HOMOSALATE, OCTISALATE, AND ZINC OXIDE.
What is the NDC code for Obagi Skintrinsiq Brightening Protocol ?
The NDC (National Drug Code) for Obagi Skintrinsiq Brightening Protocol is 62032-905, listed by Obagi Cosmeceuticals LLC.
Other Homosalate, Brands
See all →- Obagi Medical Back to Basics (Including Obagi Medical Professional-C Serum 15)62032-694
- Obagi Nu-Derm FX System Normal - Dry Skin Transformation Complexion Brightening System62032-539
- Obagi Medical Way to Glow Kit62032-690
- Obagi Nu-Derm FX System Normal - Oily Skin Transformation Complexion Brightening System62032-538
- JLo Beauty That Big Screen Broad Spectrum SPF 30 Moisturizer150 mg/mL79625-001
- SUN SHIELD BROAD SPECTRUM SPF 50 MATTE SUNSCREEN100 mg/g62032-140
- Obagi Medical Back to Basics (Including Obagi Medical Professional-C Serum 20)62032-693
Not medical advice. Always consult your doctor or pharmacist before making any medication decisions.
Data from openFDA · Public domain (CC0 1.0)